Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive data.
This move came to light following a official document dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative later stated that the United States was demanding access to genetic material for scientific study and profit but was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to find a agreement agreeable to all parties so the nation's critical HIV programme can be sustained.
Wider Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court halted a similar deal with the US following legal challenges were filed about the security of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.
Based on statements, Sixteen nations in Africa have to date signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our citizens should a future health crisis emerge."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already established through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome further dialogue with our US partners on how subsequent collaboration could be designed in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that talks should continue since much of the nation's Aids initiatives relied on external financing.
"If technical issues arise, including those relating to information security or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group said.
The situation underscores the continuing tensions between accepting much-needed foreign assistance and protecting a country's data in an ever more data-driven world.